Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/421
Subject | Predicate | Object | Context |
---|---|---|---|
dailymed-drugs:421 | rdf:type | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:421 | rdf:type | dailymed-instance:drugs | lld:dailymed |
dailymed-drugs:421 | rdfs:label | Bacitracin Zinc and Polymyxin B Sulfate (Ointment) | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:dosage | Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:descripti... | Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP is a sterile antimicrobial ointment formulated for ophthalmic use. Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units per mg. The structural formula for bacitracin A is: Polymyxin B sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formulae are: Each Gram Contains: ACTIVES: Bacitracin Zinc equal to 500 bacitracin units and Polymyxin B Sulfate equal to 10,000 polymyxin B units; INACTIVES: White Petrolatum and Mineral Oil. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:clinicalP... | Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species. Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:activeIng... | dailymed-ingredient:Bacitra... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:contraind... | This product is contraindicated in those individuals who have shown hypersensitivity to any of its components. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:supply | Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP is available in tubes with an ophthalmic tip applicator in the following size: 3.5 gram tube - Prod. No. 07534 DO NOT USE IF CAP AND NECKRING ARE NOT INTACT. STERILE OPHTHALMIC OINTMENT Rx only | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:activeMoi... | dailymed-ingredient:BACITRA... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:inactiveI... | dailymed-ingredient:White_P... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:inactiveI... | dailymed-ingredient:Mineral... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:precautio... | General: As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures should be taken if this occurs. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:genericMe... | Bacitracin Zinc and Polymyxin B Sulfate | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:fullName | Bacitracin Zinc and Polymyxin B Sulfate (Ointment) | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:warning | Ophthalmic ointments may retard corneal healing. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:indicatio... | For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate. | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:represent... | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:routeOfAd... | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:421 | dailymed-instance:name | Bacitracin Zinc and Polymyxin B Sulfate | lld:dailymed |
http://www4.wiwiss.fu-berli... | dailymed-instance:producesD... | dailymed-drugs:421 | lld:dailymed |